F-group (family)
2002.1.1.115 Glyco_hydro_79n
Ligands and drugs
80
Member domains
40
with ligand contacts (≤ 4 Å)
50.0% of members
30
with DrugDomain annotations
37.5% of members
21
with a DrugBank compound
26.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.115 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 8 |
| DB04417 | NPO | P-Nitrophenol | 2 |
| DB03156 | BDP | beta-D-glucuronic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 19 |
| CL | CHLORIDE ION | 12 |
| VGO | (3~{S},4~{S})-4,5,5-tris(oxidanyl)piperidine-3-carboxylic acid | 3 |
| 6S6 | (1~{S},2~{R},3~{S},4~{S},5~{S},6~{R})-2-(8-azidooctylamino)-3,4,5,6-tetrakis(oxidanyl)cyclohexane-1-carboxylic acid | 2 |
| GUX | (1~{R},2~{S},3~{R},4~{S},5~{S},6~{R})-7-[8-[(azanylidene-{4}-azanylidene)amino]octyl]-3,4,5-tris(oxidanyl)-7-azabicyclo[4.1.0]heptane-2-carboxylic acid | 2 |
| NPO | P-NITROPHENOL | 2 |
| OUU | (1~{S},2~{R},3~{R},4~{S},6~{S})-2-(2-acetamidoethoxy)-3,4,6-tris(oxidanyl)cyclohexane-1-carboxylic acid | 2 |
| OV3 | (1~{S},2~{R},3~{R},4~{S},6~{S})-3,4,6-tris(oxidanyl)-2-[2-[2,2,2-tris(fluoranyl)ethanoylamino]ethoxy]cyclohexane-1-carboxylic acid | 2 |
| SJ5 | (3S,4R,5R)-4,5-dihydroxypiperidine-3-carboxylic acid | 2 |
| VP5 | (3~{S},4~{R})-4,5,5-tris(oxidanyl)piperidine-3-carboxylic acid | 2 |
| 8I4 | (2R,3S,5R,6R)-2,3,4,5,6-pentakis(oxidanyl)cyclohexane-1-carboxylic acid | 1 |
| BDP | beta-D-glucopyranuronic acid | 1 |
| DNF | 2,4-DINITROPHENOL | 1 |
| GUF | 2-deoxy-2-fluoro-beta-D-glucopyranuronic acid | 1 |
| GUZ | 2-deoxy-2-fluoro-alpha-D-glucopyranuronic acid | 1 |
| IUV | (5~{S},6~{R},7~{S},8~{S})-6,7,8-tris(oxidanyl)-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid | 1 |
| IVO | (5~{S},6~{R},7~{S},8~{S})-6,7,8-tris(oxidanyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid | 1 |
| J13 | (1S,2R,3R,4S,6S)-6-[(8-azidooctanoyl)amino]-2,3,4-trihydroxycyclohexane-1-carboxylate | 1 |
| NAmetal | SODIUM ION | 1 |
| QG2 | (2~{S},3~{S},4~{R},5~{R},6~{S})-3-[(2~{R},3~{R},4~{R},5~{S},6~{R})-4,5-bis(oxidanyl)-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-6-(4-methyl-2-oxidanylidene-chromen-7-yl)oxy-4,5-bis(oxidanyl)oxane-2-carboxylic acid | 1 |